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Summary of Background data 
Unspecified kidney donation (UKD) describes living donation of a kidney to a stranger. The 
practice is playing an increasingly important role within the transplant programme in the 
United Kingdom, where these donors are commonly used to trigger a chain of transplants; 
thereby amplifying the benefit derived from their donation. The initial reluctance to accept 
UKD was in part due to uncertainty about donor motivations and whether the practice was 
morally and ethically acceptable.  
 
Objectives  
This article provides an overview of UKD and answers common questions regarding the ethical 
considerations, clinical assessment and how UKD kidneys are used in order to maximise utility. 
Existing literature on outcomes after UKD are also discussed, along with current controversies.  
 
Conclusions 
We believe UKD is an ethically acceptable practice which should continue to grow, despite its 
controversies. In our experience, these donors are primarily motivated by a desire to help others 
and utilisation of their kidney as part of a sharing scheme means that many more people seek 
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For individuals with end-stage kidney disease a transplant is the only way of removing the need 
for renal replacement therapy. Countries differ in their laws, degrees of public engagement and 
financial investment in transplantation and support either or both living and deceased donation 
to varying degrees. A living donor kidney transplantation results in better survival rates relative 
to dialysis, and longer graft survival than a transplant from a deceased donor 1. The term 
‘unspecified kidney donation’ (UKD) (also known as ‘altruistic’ and ‘non-directed donation’) 
describes living donation of a kidney to a stranger 2. Despite a lack of international consensus 
on the ethical and legal aspects of UKD, it has become an established practice in the United 
Kingdom (UK) and in the United States of America (USA), whilst remaining illegal in many 
countries across the world. The practice also It is making an increasingly significant 
contribution to the number of transplants generated through the UK Living Kidney Sharing 
Scheme (UKLKSS) and consequently plays a significant role in reducing waiting times for 
patients on the kidney transplant waiting list.  
 
Despite its healthcare benefits and controversies, UKD is rarely discussed outside the 
transplant community. The initial reluctance to accept UKD was in part due to uncertainty 
about donor motivations what would motivate someone to accept the risks of major surgery in 
the interest of a complete stranger, and whether the desire to donate to a stranger so was 
psychopathological. Whilst increased clinical experience has significantly attenuated these 
fears, they have not yet been completely allayed 3. 
 
ETHICAL CONSIDERATIONS 
For some clinicians, UKD is a logical extension of specified kidney donation (SKD), where a 
family member or friend is the donor. The common ethical hurdle for all living donation is that 
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in addition to contravening the primary principle of medical practice to ‘first do no harm’, it 
goes one step further and places those by placing harms and risks of surgery upon an otherwise 
healthy person for the benefit of someone else. The case for SKD is easier to argue because the 
recipient is known to the donor and it is not simply the harms to the potential donor and the 
benefits to the recipient that must be considered, but additionally the relative harms of not 
proceeding with living donation. For example, it may be argued that a parent will may 
experience greater harm from the death or continued suffering of their child than from the 
harms and risks of surgery to themselves. With respect to UKD, the ethical issues are further 
complicated by the absence of a relationship between donor and recipient. The potential 
benefits to the donor from the act of donation become more abstract and may draw on more 
general ethical obligations to do good, or to maximise overall utility when deciding how to 
behave.  
 
We believe UKD is an ethically acceptable practice which should continue to grow, despite its 
controversies. Evidence suggests that In our experience, unspecified kidney donors (UKDrs) 
are primarily motivated by a desire to help someone in need; with the donation making little 
difference to them directly, but a significant difference to someone else 4. The desire to donate 
is frequently in keeping with similarly benevolent behaviours elsewhere in the donor’s life and 
the choice to donate appears to be a natural extension of their self-identity and sense of social 
responsibility 5. These beliefs and characteristics may help to address some of the theoretical 
ethical concerns with the concept of UKD: their settled and stable preferences speak to the 
issue of whether UKDrs are likely to be appropriately autonomous; they appear to be 
consistently well motivated and virtuous; and, their apparently systematic approach to 




BECOMING AN UNSPECIFIED KIDNEY DONOR IN THE UNITED KINGDOM 
Guidelines published by the British Transplantation Society (BTS) and Renal Association (RA) 
require that all living kidney donors undergo rigorous assessment 3. The physical components 
are identical for unspecified and specified kidney donors (SKDrs) and determine whether an 
individual is fit enough to survive surgery, whether the kidney is suitable for transplantation 
and whether the donor’s remaining kidney is likely to provide sufficient life-long renal 
function. After completion of standard tests potential donors are assessed by a nephrologist and 
a transplant surgeon before discussion at a multidisciplinary team meeting. Finally, the 
individual is interviewed by an Independent Assessor who is appointed and trained by the 
Human Tissue Authority to ensure that the legal requirements have been met and that no reward 
is being sought or offered, and that there is no coercion. The assessment of UKDrs and SKDrs 
does differ in the requirement for a formal mental health assessment, which is recommended 
for all UKDrs, whereas it but is optional for SKDrs 3. This is based on a consensus among 
mental health clinicians working within the field of transplantation and the format and 
justification for this is outlined in the BTS/RA Guidelines. 
 
MAXIMISING THE UTILISATION OF UNSPECIFIED DONOR KIDNEYS 
Since 2018 all UKDr kidneys are directed towards the UKLKSS, provided that there is no 
compatible higher priority patient on the national transplant waiting list. The UKLKSS 
facilitates transplants between blood group and human leucocyte antigen (HLA) incompatible 
SKD donor-recipient pairs by exchanging kidneys with one or more other donor-recipient pairs 
or compatible pairs that seek a . Compatible pairs may also register to achieve a better HLA or 
age matched transplant. Donors and recipients are characterised by their demographic and 
clinical data prior to being entered into the scheme and optimal combinations of transplants are 




UKDrs are used within the UKLKSS to trigger a chain of transplants (called ‘altruistic donor 
chains’) between two or more incompatible donor-recipient pairs (Figure 1). The remaining 
organ from the donor at the end of the chain is then allocated to a recipient on the national 
transplant list according to national allocation criteria. Incorporating UKDrs into the UKLKSS 
maximises the benefit derived from each donation by increasing the number of transplants it 
facilitates. For example, 89 UKDrs donated between April 2017 and April 2018, resulting in a 
total of 138 transplants. This was possible due to 33 UKDrs (37.1%) being entered into donor 
chains, resulting in 82 transplants 6. The nature of the UKLKSS is such that it typically includes 
individuals who are more difficult to transplant and therefore provides opportunities for 
individuals to have a living donor transplant who otherwise may never receive a transplant 
would never receive one (i.e. due to immunological complexity), as well as increasing 
opportunities for all patients on the national transplant list. Due to the level of organisation 
required, sharing schemes such as these are likely only to be possible in countries with 
established transplant programmes. We are in favour of utilising UKDr kidneys in this way as 
it maximises the benefits of UKD with minimal additional risk.  
 
OUTCOMES AFTER UNSPECIFIED KIDNEY DONATION 
Although there is a paucity of research, available evidence suggests that physical outcomes for 
UKDrs and SKDrs are comparable, despite UKDrs being on average 10 years older 4. Donors’ 
psychological outcomes are also broadly similar, with little regret 4.  Some UKDrs report an 
increase in self-esteem and feel that donation became a positive emotional anchor that was 
referred to in times of difficulty 5 7. UKDrs and SKDrs do differ significantly in levels of 
perceived social support 8, with UKDrs feeling less supported by family and friends. Lack of 
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support for donation and strong family objections have been anecdotally cited as reasons for 
withdrawing from the donation process. 
 
The BTS/RA guidelines state that UKDrs and their intended recipients must remain unknown 
to each other prior to surgery, however anonymity may be broken post-transplant with the 
consent of all parties, who initially communicate through the transplant centres. UKDrs have 
different views on anonymity, but evidence suggests that the majority would like to receive 
some communication 4. An issue of concern for both donors and the transplant community is 




Given the success of UKD programmes in the UK and USA, we do not consider the overall 
practice to be controversial. Current controversies relate to UKDrs who wish to donate another 
organ (such as a liver lobe), those who are terminally ill and those who are very young. 
Transplant professionals have raised concerns for young people coming forward as potential 
UKDrs, in particular those aged 18-25, questioning whether they possess sufficient maturity, 
life experience and wisdom to donate and whether there is greater potential for regret. Some 
UKDrs offering other organs to have also come forward to offer a lobe of their liver to an 
unspecified recipients have also caused concern, predominantly due to; the motivating factor 
being the desire to replicate the positive experience of donating a kidney. Concerns for this 
practice include the additional risks associated with living donor liver surgery and the 




Another issue within the UK are the broad differences in UKD rates across the country, UK 
vary broadly with currently over 50% of donations take place within just 5 out of 23 transplant 
centres 6. , some of which have otherwise relatively small living donor programmes. A concern 
amongst former UKDrs is that UKDrs have highlighted some negative attitudes held by 
transplant professionals towards UKD (such as an assumption of psychopathological motives) 
and have expressed concerns that these may be prolonging the time it takes for them to donate 
or prohibiting some potential donors from proceeding individuals from donating. The degree 
of variability in the numbers of UKDrs across the UK These issues warrants empirical 
investigation and a national prospective multicentre study of UKD in the UK is currently 
underway and aims to address some of these issues 10. 
 
CONCLUSIONS 
UKD is becoming increasingly routine in the UK, despite some continuing controversy. The 
utilisation of UKDrs within UKLKSS amplifies the benefits of this extraordinary gift given by 
well-motivated individuals who wish to help someone in need. Similarly to specified donors, 
UKDrs are an invaluable asset to the kidney transplantation programme and make a significant 
contribution towards reducing the waiting list. Given the concerns that surround UKD, The 
concerns surrounding UKD are understandable due to its unique nature and prospective studies 
that address these are necessary to support the wider transplant community to develop  
the programme with confidence for the benefit of potential donors and recipients.  
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Figure 1: Donation as part of an ‘Altruistic Donor Chain’ (ADC) 
 




Altruistic donor chains are created when a UKD donates to a recipient who has an incompatible living donor. That recipient’s donor then donates 
to another recipient, and so on. The chain is terminated when a final living donor donates to an individual on the transplant waiting list. In the 
example above, an altruistic donor chain results in 3 transplants from 1 UKD.  
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